|
|
The Retina Radar With Dr. Arshad Khanani on DR, GA, New Mechanisms, and Noninvasive Treatments
Retinal diseases are a leading cause of global vision impairment, driven by an increasing prevalence and the need for more effective treatment. Although clinical trials have shown promising results for various therapies, real-world application often yields less impressive outcomes due to factors like under-treatment and patient non-adherence. New and emerging therapies, particularly for conditions like diabetic macular edema (DME), diabetic retinopathy, and geographic atrophy (GA) secondary to... |
|
|
nAMD, Diabetic Eye Disease, and RVO: State-of-the-Art Management
The continued evolution of diagnostic, therapeutic, and surgical algorithms for the management of patients with retinal diseases offer the potential for enhancing visual, anatomical, and quality-of-life outcomes in these patients. Recognition, understanding, and application of these evidence-based advances are imperative to enhance treatment outcomes and patient satisfaction. During Part 1 of this 2-part educational activity, updates in state-of-the-art management strategies for neovascular ag... |
|
|
GA and Advances in Imaging and Surgery: State-of-the-Art Management
The continued evolution of diagnostic, therapeutic, and surgical algorithms for the management of patients with retinal diseases offer the potential for enhancing visual, anatomical, and quality-of-life outcomes in these patients. Recognition, understanding, and application of these evidence-based advances are imperative to enhance treatment outcomes and patient satisfaction. During Part 2 of this 2-part educational activity, updates in geographic atrophy will be discussed, along with advances... |
|
|
FcRn and Myasthenia Gravis
Target Audience
This activity has been designed to meet the educational needs of physicians specializing in neurology and ophthalmology who may be involved in the diagnosis and care of individuals with MG. Other healthcare providers, including neurology NPs and PAs, may also participate.
Program Overview
This 30-minute CME program discusses how the FcRn system can impact myasthenia gravis and how FcRn antagonists can be used to treat this rare condition.
Learning Objectives
After part... |
|
|
Cleveland Clinic Thyroid Expo (Online Streaming On Demand)
he Cleveland Clinic Thyroid Expo provides an updated review of the many multidisciplinary guidelines for the treatment of thyroid disorders. An expert faculty addresses topics such as molecular applications in thyroid neoplasia, cancer care, practical management tips and advances in laboratory testing. It focuses on new technologies in thyroid surgery, with a goal of increasing competence and clinical performance in managing routine and complex patient cases.
Worth 5 AMA PRA Category I C... |
|
|
Cleveland Clinic Children's 30th Annual Pediatric Board Review (Online Streaming & USB Formats)
Cleveland Clinic Children’s 30th Annual Pediatric Board Review is a nationally recognized, comprehensive activity that will benefit all clinicians practicing in this critical area of medicine. Primarily designed to prepare physicians for board certification or re-certification, this heavily detailed resource can help enhance clinical skills throughout the pediatric practice. A wide variety of topics are introduced in question and answer format, which highlights board relevant information and... |
|